Somatic PTPN11 mutations in childhood acute myeloid leukaemia
Open Access
- 19 April 2005
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 129 (3), 333-339
- https://doi.org/10.1111/j.1365-2141.2005.05457.x
Abstract
Somatic mutations in PTPN11, the gene encoding the transducer SHP‐2, have emerged as a novel class of lesions that upregulate RAS signalling and contribute to leukaemogenesis. In a recent study of 69 children and adolescents with de novo acute myeloid leukaemia (AML), we documented a non‐random distribution of PTPN11 mutations among French–American–British (FAB) subtypes. Lesions were restricted to FAB‐M5 cases, where they were relatively common (four of 12 cases). Here, we report on the results of a molecular screening performed on 181 additional unselected patients, enrolled in participating institutions of the Associazione Italiana Ematologia Oncologia Pediatrica–AML Study Group, to provide a more accurate picture of the prevalence, spectrum and distribution of PTPN11 mutations in childhood AML and to investigate their clinical relevance. We concluded that PTPN11 defects do not represent a frequent event in this heterogeneous group of malignancies (4·4%), although they recur in a considerable percentage of patients with FAB‐M5 (18%). PTPN11 lesions rarely occur in other subtypes. Within the FAB‐M5 group no clear association of PTPN11 mutations with any clinical variable was evident. Nearly two third of the patients with this subtype were found to harbour an activating mutation in PTPN11, NRAS, KRAS2 or FLT3.Keywords
This publication has 28 references indexed in Scilit:
- NOONAN SYNDROME AND RELATED DISORDERS: Genetics and PathogenesisAnnual Review of Genomics and Human Genetics, 2005
- Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factorBlood, 2005
- PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer GroupLeukemia, 2004
- Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemiaBlood, 2004
- Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesisBlood, 2004
- Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor SignalingMolecular and Cellular Biology, 2003
- The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signalingTrends in Biochemical Sciences, 2003
- Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemiaNature Genetics, 2003
- GENETICS OF MYELOID LEUKEMIASAnnual Review of Genomics and Human Genetics, 2002
- The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early xenopus developmentCell, 1995